8/26/2021 9:21:12 AM
Rite Aid Announces 'Back To School' COVID-19 Testing Program
8/16/2021 9:57:01 AM
BioReference Labs Buys U.S. Ariosa Centralized Laboratory Prenatal Testing Business
6/22/2021 8:25:02 AM
OPKO Health Appoints Katherine Stueland As President And CEO Of GeneDx
6/22/2021 7:44:32 AM
BioReference Laboratories Announces First COVID-19 Testing Program For Cruise Industry
6/21/2021 8:29:00 AM
OPKO Health Enters Agreement With Nicoya Macau To Develop RAYALDEE In Greater China
6/21/2021 8:15:55 AM
OPKO Health Enters Agreement With Nicoya Macau Limited To Develop, Commercialize RAYALDEE In China
1/26/2021 8:38:51 AM
OPKO Health's BioReference Labs Joins Hands With NBA And NHL To Provide Players And Staff With COVID-19 Testing
1/4/2021 6:49:24 AM
Pfizer: FDA Accepts For Filing The Initial BLA For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency
12/31/2020 8:43:18 AM
Buffalo Bills And OPKO Health's BioReference Labs Initiate First Large Scale, Mandatory COVID-19 Fan Testing Program
10/9/2020 8:06:48 AM
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program For New York City Schools
9/2/2020 8:07:58 AM
OPKO Health's BioReference Labs Announces New York City Schools COVID-19 Testing Program
7/1/2020 8:23:07 AM
BioReference Lab Reports Results Of COVID-19 Molecular PCR Tests For Nursing Home And Live-in Facility Employees
6/9/2020 8:15:53 AM
OPKO Health Announces Japan Phase 3 Clinical Trial Met Its Primary And Secondary Objectives
6/1/2020 8:06:39 AM
OPKO Health Says FDA Authorizes Clinical Trial Evaluating RAYALDEE In COVID-19 Patients
5/13/2020 8:34:23 AM
OPKO Health's BioReference Labs, Westchester Medical Center Collaborate To Deliver Operational And Diagnostic Services